(2R)-1-(2,4-Difluorophenyl)-2-((tetrahydro-2H-pyran-2-yl)oxy)propan-1-one, 97%, 5g

2-Fluorobenzaldehyde, 97.0%, 500g

1,2-Dichloroethane, min. 99%, for synthesis, 2.5 L, glass packaging

1-(4-Bromophenyl)-2-phenyl-1H-benzo[d]imidazole, 95.0%, 100g

Ethyl 5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepine-2-carboxylate, 98%, 100mg

2-Amino-7-hydroxy-1,8-naphthyridine, 95.0%, 25g

2-(Tert-butyl)anthracene, 98%, 25g

4-(3-Bromo-5-fluorophenyl)morpholine, 95.0%, 1g

2-(5-BROMO-1,3-THIAZOL-2-YL)PROPAN-2-OL, 95%, 1g

3-Chloro-N-(2,2,2-trifluoroethyl)aniline, 95%, 100mg

2-Chloro-6-methylphenol, 97.0%, 500g

3,5-Dichloro-2-fluoro-4-iodopyridine, 95.0%, 1g

4-(2-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)propan-2-yl)phenethyl 4-methylbenzenesulfonate, 97%, 10g